Explore Diverse Perspectives.

Browser Extension

Sunday, June 1, 2025

US Edition

Subscribe Login

Israel-Hamas Conflict

Champions League

Artificial Intelligence

Natural Disasters

Labiotech.eu image

News from Labiotech.eu

Topics Most Covered by Labiotech.eu

Artificial Intelligence

Artificial Intelligence

Sources Covering Similar Topics

Purdue Exponent

Delaware Business Now

Your Alaska Link

Purdue Exponent

Delaware Business Now

Suggest a source

Looking for a source we don't already have? Suggest one here.

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Champions League Social Media Drones Artificial Intelligence Natural Disasters

Trending in U.S.Israel-Hamas Conflict US Politics Donald Trump NCAA Baseball

Trending in U.K.Israel-Hamas Conflict Premier League Manchester United UK Economy Celtic

Trending Topics

Champions League Social Media Drones Artificial Intelligence Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from Labiotech.eu

See all of Labiotech.eu news coverage in one place. Discover how Labiotech.eu’s media bias informs their coverage and compare with thousands of other news outlets.

Ground News has come across 53 headlines reported on by Labiotech.eu during the past 3 months.

The Ground News media bias check for Labiotech.eu is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Is Labiotech.eu credible or reliable? Our Factuality score answers both of those questions. When it comes to Labiotech.eu, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

See all of Labiotech.eu news coverage in one place. Discover how Labiotech.eu’s media bias informs their coverage and compare with thousands of other news outlets. Ground News has come across 53 headlines reported on by Labiotech.eu during the past 3 months.

The Ground News media bias check for Labiotech.eu is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides. Is Labiotech.eu credible or reliable? Our Factuality score answers both of those questions. When it comes to Labiotech.eu, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about Labiotech.eu

Where is Labiotech.eu located?Labiotech.eu's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Labiotech.eu News

The state of biotech finance and fundraising in Q2 2025 with Baker Mackenzie - Beyond Biotech - the podcast from Labiotech

Germany · Germany

The state of biotech finance and fundraising in Q2 2025 with Baker Mackenzie - Beyond Biotech - the podcast from Labiotech

Trying to predict where the market for biotech investment is heading is risky but for experts like Baker Mackensie’s Roel Meers, understanding where the market is moving is where he eats. The post The state of biotech finance and fundraising in Q2 2025 with Baker Mackenzie appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s a…Read Article

Gene Therapy in Dermatology: A Promising Field Gaining Momentum

Germany · Germany

Gene Therapy in Dermatology: A Promising Field Gaining Momentum

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of something more? The post Gene therapy for skin diseases: A field still finding its footing appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and l…See the Story

European biotech: trends to watch in 2025

European biotech: trends to watch in 2025

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global policies. The post European biotech: trends to watch in 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full a…Read Article

Breaking News Topics Related to Labiotech.eu

Artificial Intelligence

Germany

United States

Medical

Science

Similar News Topics

Webster County Citizen

Denver Gazette

The Indiana Gazette Online

Purdue Exponent

Pharmaphorum

The genomics layoff wave in the US: What is happening and why

The genomics layoff wave in the US: What is happening and why

Genomics companies have been slashing jobs and culling programs in the US. Learn about the layoffs that have struck the industry in 2025. The post Layoffs in the US: what is going on with genomics companies? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may …United States · United States Read Article

Seven lung cancer companies advancing new treatments in 2025

Seven lung cancer companies advancing new treatments in 2025

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to bispecific antibodies. The post Seven lung cancer companies advancing new treatments in 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links m…Germany · Germany Read Article

Watch these 9 small molecule drug discovery companies in 2025

Watch these 9 small molecule drug discovery companies in 2025

Discover nine small molecule drug discovery companies that have raised funding for their novel medicines in the last year. The post Nine promising small molecule drug discovery companies to look out for in 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links m…Medical Read Article

Fighting mucopolysaccharidosis type I, a rare disease, by reprogramming B-cells - Beyond Biotech - the podcast from Labiotech

Fighting mucopolysaccharidosis type I, a rare disease, by reprogramming B-cells - Beyond Biotech - the podcast from Labiotech

There are cell therapies, gene therapies, and biologics – and then there is Immusoft. Immusoft sits at the nexus point of some of the most innovative approaches in biopharma, and their Immune System Programming platform is unique in its capacity to address the rare disease, MPS I. This ...Biotech · Germany Read Article

Cracking the code: Delivering biotherapeutics successfully across EMEA

Cracking the code: Delivering biotherapeutics successfully across EMEA

Learn how to optimize cold chain logistics for biotherapeutics in EMEA and overcome key challenges in delivery and regulation. The post Cracking the code: Delivering biotherapeutics successfully across EMEA appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may b…Regulation Read Article

Pharma Giants Pull Back On AAV Research: What’s Next For The Gene Therapy Space?

Pharma Giants Pull Back On AAV Research: What’s Next For The Gene Therapy Space?

Newsletter Signup – Under Article / In Page “*” indicates required fields Once hailed as the solution to delivering gene therapies, adeno-associated virus (AAV) vectors have seen their star dim in recent years. Initially touted for its potential to treat a number of genetic disorders, the dwindle in research has now become apparent. The latest biopharma to scale back on AAV research is Vertex Pharmaceuticals, in a blow to the technological space…Germany · Germany See the Story

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

60% Center coverage: 145 sources

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medicationsHealth · United States See the Story

World-first wearable diabetes monitor being developed with EU funding boost

World-first wearable diabetes monitor being developed with EU funding boost

Glucowear is worn on the wrist and uses ultra-low power microwave signals to monitor glucose. Image: Afon Technology/Welsh Government A Welsh business is developing a potentially revolutionary way of managing diabetes after receiving funding from the world’s largest research collaboration programme. Afon Technology Ltd is working on a world-first wearable non-invasive blood glucose sensor, which measures levels in real-time – eliminating the nee…Diabetes See the Story